Sphincter of oddi dysfunction induced by ketamine: A case report.
biliary diseases
drug abuse
low‐dose ketamine
sphincter of oddi dysfunction
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
20
06
2023
revised:
30
03
2024
accepted:
13
05
2024
medline:
27
5
2024
pubmed:
27
5
2024
entrez:
27
5
2024
Statut:
epublish
Résumé
Chronic ketamine use can lead to sphincter of oddi dysfunction (SOD), causing various hepatobiliary complications. Recognizing substance abuse history is vital for early detection. Timely intervention can prevent irreversible liver and pancreas damage. Ketamine is commonly abused as a recreational drug worldwide due to its ability to induce euphoria-like effects. Ketamine abuse is associated with many hepatobiliary side effects ranging from cholestasis to biliary sepsis and death. Here we present a case of a young 29-year female with upper abdominal pain due to SOD resulting from chronic use of ketamine. SOD can result in obstruction or dysfunction of the bile and pancreatic ducts. Ketamine induces SOD by activation of the muscarinic receptors in the sphincter of oddi. Detail history of substance abuse is crucial for early identification of ketamine-induced SOD. Early identification and treatment of this rare condition can prevent permanent injury to the liver and pancreas.
Identifiants
pubmed: 38799518
doi: 10.1002/ccr3.9016
pii: CCR39016
pmc: PMC11126637
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e9016Informations de copyright
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None.